First phase of corona virus vaccine test on humans, first dose given to a person in AIIMS

More than 3,500 people have registered themselves for testing at AIIMS since last Saturday, of which at least 22 are under screening.

Corona Vaccine : Trial if Covavin started by AIIMS

New Delhi: The first phase of clinical trial on humans of ‘Covaxin’, India’s first indigenously developed vaccine for the prevention of Novel Corona virus, started at AIIMS on Friday. A person between the ages of 30 and 40 years was given the first injection.

More than 3,500 people have registered themselves for testing at AIIMS since last Saturday, of which at least 22 are under screening. This information was given by Dr. Sanjay Rai, Professor and Chief Studyer of Community Medical Center at AIIMS.

Rai told, “The first person from Delhi was examined two days ago and all his health parameters were found to be in the normal range. He does not have any other disease. The first dose of 0.5 ml from the injection was given to him around 1.30 pm. No side effects have been seen so far. She is under supervision for two hours and will be monitored for the next seven days. ”

They will be vaccinated on Saturday after screening reports of some more participants involved in the clinical trial.
. The Indian Council of Medical Research (ICMR) has selected 12 institutes, including AIIMS, for clinical trials in the first and second phases of ‘Covaxin’.

[amazon box=”B07VJ92G95″ “small”]

The first phase will test 375 people and maximum of them will be from 100 AIIMS. According to Rai, in the second phase, a total of around 750 people from all 12 institutions will be involved.

In the first phase, the vaccine will be tested on healthy people between 18 and 55 years who do not have any other disease. According to AIIMS director Dr. Randeep Guleria, in the second phase, this test will be done on 750 people between the ages of 12 and 65 years.